• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Prognostic values of chemokines in different clinical outcomes of influenza A (H1N1)-infected patients

tetano

Editor, Senior Moderator
Zhonghua Yi Xue Za Zhi. 2012 Aug 7;92(29):2020-2.
[Prognostic values of chemokines in different clinical outcomes of influenza A (H1N1)-infected patients].
[Article in Chinese]
Zhang YH, Wang S, Yan HP, Zhao DT, Zhang X, Li A, Wang ZK, Wu H, Zhao Y.
Source

Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
Abstract
OBJECTIVE:

To analyze the prognostic values of chemokines in different clinical outcomes of influenza A (H1N1)-infected patients.
METHODS:

A total of 60 cases with influenza A (H1N1) virus were enrolled. There were 32 mild cases, 16 healing cases from severe stage and 12 mortality cases resulting from severe stage. The serum levels of chemokines including CXCL8, CCL10, CCL2, CCL3, CCL4, CCL5 and CCL11 were detected by the Luminex technique.
RESULTS:

The levels of CXCL8, CCL2 and CCL10 in the mortality group were higher than those of the healing serve and mild cases. And the differences were significant. P value was 0.001, < 0.0001 and 0.027 respectively. The thresholds of CCL2 and CXCL8 for predicting clinical mortality were 45.99 ng/L (sensitivity 100%, specificity 89.58%) and 59.75 ng/L (sensitivity 75%, specificity 95.83%).
CONCLUSION:

The serum levels of chemokines are elevated in severe cases of influenza A (H1N1). And the rises of CXCL8 and CCL2 are more obvious in the mortality cases. Thus CXCL8 and CCL2 may serve as two prognostic indices for the clinical fatal outcomes.

PMID:
23253800
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23253800
 
Back
Top Bottom